← Leaderboards
Ilana F Gareen
Brown University
$3,961,097
Attributed
$3,961,097
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $850.1K · FY2009–23$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,961,097 · 3
By mechanism
R01$3,799,431 · 2
R03$161,666 · 1
Top collaborators
No co-investigators on record.
Most similar at Brown University
Same institution · by research overlap
- Terrie F Wetle$3,455,767
- Vincent Mor$57,855,506
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantLungReportingScreening ResultMalignant NeoplasmsDiagnosisThoracic RadiographyDiagnosticMalignant Neoplasm Of LungUnited StatesLeadBaseCancer DiagnosisDetectionIatrogenesisIncidental FindingsLung Cat ScanInsurance CoverageMedicalHealth Care Service UtilizationAffordable Care ActHigh RiskCostCost Effectiveness
Grant awards (13)
Lung Screening: Efficacy versus Effectiveness$488,886
R01 · FY2023 · CA · contact PI
Lung Screening: Efficacy versus Effectiveness$515,456
R01 · FY2022 · CA · contact PI
Lung Screening: Efficacy versus Effectiveness$509,518
R01 · FY2021 · CA · contact PI
Outcomes associated with significant incidental findings in lung cancer screening$184,307
R01 · FY2021 · CA · contact PI
Outcomes associated with significant incidental findings in lung cancer screening$277,084
R01 · FY2020 · CA · contact PI
Lung Screening: Efficacy versus Effectiveness$3,521
R01 · FY2020 · CA · contact PI
Lung Screening: Efficacy versus Effectiveness$495,096
R01 · FY2019 · CA · contact PI
Outcomes associated with significant incidental findings in lung cancer screening$130,047
R01 · FY2019 · CA · contact PI
Lung Screening: Efficacy versus Effectiveness$532,539
R01 · FY2018 · CA · contact PI
Outcomes associated with significant incidental findings in lung cancer screening$317,576
R01 · FY2018 · CA · contact PI
Outcomes associated with significant incidental findings in lung cancer screening$345,401
R01 · FY2017 · CA · contact PI
Compliance With Lung Cancer Screening$80,979
R03 · FY2010 · CA · contact PI
Compliance With Lung Cancer Screening$80,687
R03 · FY2009 · CA · contact PI